More than 1,100 primary care physicians and more than 1,100 oncologists across the country were surveyed in 2009. Both types of physicians were asked to identify the side affects associated with four common chemotherapy drugs for breast and colon cancer.
Researchers found that only 6 percent of primary care physicians were able to identify the long-term side effects of all four drugs, while 65 percent of oncologists were able to do so. Key side effects included heart problems, nerve damage and early menopause.
Michael Link, MD, president of the American Society of Clinical Oncology, said the study shows “there is a lot to work to be done” in terms of communication between oncologists and primary care physicians. He also said the findings make a case for electronic medical records, which can more easily provide primary care physicians with a patient’s medication history and information on drugs’ side effects.
More Articles on Oncologists:
Medical Oncologists’ Reimbursement Incentivizes Choosing High-Cost Meds
70 Hospitals and Health Systems With Great Oncology Programs
7 Steps for Hospitals to Recruit Specialists in a Competitive Market
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
